| Literature DB >> 28613267 |
Nayely Leyva-López1, Erick P Gutiérrez-Grijalva2, Gabriela Vazquez-Olivo3, J Basilio Heredia4.
Abstract
Essential oils of oregano are widely recognized for their antimicrobial activity, as well as their antiviral and antifungal properties. Nevertheless, recent investigations have demonstrated that these compounds are also potent antioxidant, anti-inflammatory, antidiabetic and cancer suppressor agents. These properties of oregano essential oils are of potential interest to the food, cosmetic and pharmaceutical industries. The aim of this manuscript is to review the latest evidence regarding essential oils of oregano and their beneficial effects on health.Entities:
Keywords: anti-inflammatory; antidiabetic; antioxidant; oregano species; terpenoids
Mesh:
Substances:
Year: 2017 PMID: 28613267 PMCID: PMC6152729 DOI: 10.3390/molecules22060989
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Some of the major constituents of the essential oils of oregano.
Principal components of essential oils of different oregano species.
| Oregano Species | Origin | Components | Yield * | Reference |
|---|---|---|---|---|
| Mexico | Thymol, | NR | [ | |
| Brazil | Carvacrol (37.12%), | 2.7% | [ | |
| Mexico | Thymol, carvacrol acetate, carvacrol, camphene, β-myrcene, γ-terpinene, cis-p-mentha-1(7),8-dien-2-ol, viridiflorol. | NR | [ | |
| Colombia | Thymol (78.7%), | NR | [ | |
| Mexico | Thymol, α-cedrene, | NR | [ | |
| Mexico | Carvacrol (8.76–24.57%), | 5.0–6.0% | [ | |
| Turkey | Carvacrol (76.21%), | 1.45% | [ | |
| Turkey | Carvacrol (65.13%), | 3.1% | [ | |
| Argentina | Thymol (30.77%), | 1.83 ± 0.27 mg/g dw | [ | |
| Lebanon | Carvacrol (79.0%), | 3.19% | [ | |
| Turkey | Carvacrol (84.30–90.20%), | 0.54–0.57% | [ | |
| Lebanon | β-Caryophyllene (26.8%), caryophyllene oxide (22.6%), germacrene D (17.2%), thymol methyl ether (10.5%). | 0.16% | [ | |
| Brazil | 1,8-Cineole (20.9%), terpinen-4-ol(20.4%), γ-terpinene (8.5%), | NR | [ | |
| Colombia | NR | [ | ||
| Turkey | Limonene (88.01%), thymol (11.98%). | NR | [ | |
| Argentina | NR | [ | ||
| Argentina | 3.9 ± 0.25 mg/g dw | [ | ||
| Turkey | 2.9% | [ | ||
| Greece | Carvacrol (79.63%), γ-terpinene (3.89%), | 3.62% | [ | |
| Greece | Carvacrol (62.6%), | NR | [ | |
| Greece | Carvacrol (69.0–92.6%), | 3.0–7.0% | [ | |
| Turkey | Carvacrol (85.86%), γ-terpinene (4.43%), β-phellandrene (3.20%), | 4.7 ± 0.06% | [ | |
| Turkey | Carvacrol (83.97–88.65%), thymol (0.80–7.48%), γ-terpinene (2.63–6.15%), | 2.5–3.2% | [ | |
| Egypt | Carvacrol (81.38%), | 5.5% | [ | |
| Egypt | Thymol (31.73%), γ-terpinene (14.32%), linalool (9.44%), terpinen-4-ol (7.68%). | 4.63% | [ | |
| Egypt | Thymol (21.04%), γ-terpinene (18.96%), terpinen-4-ol (17.20%), α-terpinene (7.41%). | 0.6% | [ | |
| Lebanon | Carvacrol (60.8%), | 1.65% | [ | |
| Jordan | Thymol (51.8%), carvacrol (34.4%), | 2.0–2.2% | [ | |
| Jordan | Thymol (72.4%), γ-terpinene (7.8%), | 2.0–2.2% | ||
| Argentina | NR | [ | ||
| Argentina | Carvacrol (26.70%), | NR | [ | |
| Argentina | γ-Terpinene (25.1%), terpinen-4-ol (16.7%), carvacrol (16.2%), α-terpinene (8.54%). | NR | [ | |
| Argentina | γ-Terpinene (32.1%), α-terpinene (15.1%), | NR | [ | |
| Argentina | Carvacrol (81.92%), γ-terpinene (4.49%), thymol (3.5%), | NR | [ | |
| Brazil | Carvacrol (73.9%), γ-terpinene (3.6%), thymol (3.0%), β-caryophyllene (2.8%). | NR | [ | |
| Chile | cis-β-Terpineol (16.49%), thymol (13.26%), terpinen-4-ol (10.24%), α-terpineol (4.35%). | NR | [ | |
| China | Carvacrol (30.73%), thymol (18.81%), | NR | [ | |
| China | β-Citronellol (85.3%), citronellol acetate (5.2%), β-citronellal (1.2%). | 0.7% | [ | |
| China | Thymol (42.9%), citronellol (12.2%), β-caryophyllene (7.8%), | 0.3% | [ | |
| China | β-Citronellol (75.0%), geraniol (7.7%), citronellol acetate (3.4%). | 0.3% | [ | |
| China | 1,8-Cineole (20.8%), β-caryophyllene (10.2%), eugenol methyl ether (9.8%), citronellol (8.8%). | 0.3% | [ | |
| China | Caryophyllene oxide (32.9%), β-caryophyllene (17.7%), citronellol (10.2%), germacrene D (9.8%). | 0.1% | [ | |
| Colombia | Thymol (21.5%), | NR | [ | |
| Greece | Carvacrol (63.03%), thymol (15.09%), | NR | [ | |
| India | Carvacrol (35.02–62.81%), | 0.20–1.30% | [ | |
| Iran | Carvacrol (29.85%), γ-terpinene (20.94%), α-himachalene (12.17%), β-pinene (11.67%). | 0.80% | [ | |
| Iran | Carvacrol (23.54%), γ-terpinene (20.50%), thymol (15.41%), germacrene D-4-ol (9.26%). | 1.26% | [ | |
| Iran | Carvacrol (59.37%), γ-terpinene (18.36%), cedrene (6.65%). | 1.66% | [ | |
| Iran | Carvacrol (58.51%), humulene (11.46%), γ-terpinene (9.56%). | 0.93% | [ | |
| Iran | Carvacrol (67.09%), γ-terpinene (7.71%), humulene (7.67%). | 1.36% | [ | |
| Italy | Cavacrol (65.94%), | NR | [ | |
| Italy | Carvacrol (71.8%), | NR | [ | |
| Morocco | Carvacrol (34.0%), γ-terpinene (21.6%), | 2.7% | [ | |
| Pakistan | β-Citronellol (72.7%), thymol (7.2%), citronellol acetate (5.9%). | 0.3% | [ | |
| Poland | Carvacrol (26.38–36.72%), thymol (16.59–25.58%), γ-terpinene (10.06–16.11%), | NR | [ | |
| Portugal | Carvacrol (14.5%), β-fenchyl alcohol (12.8%), γ-terpinene (11.6%), δ-terpineol (7.5%). | NR | [ | |
| Serbia | Sabinene (10.2%), terpinen-4-ol (9.3%), 1,8-cineole (5.8%), γ-terpinene (5.6%). | 0.17% | [ | |
| Serbia | Carvacrol (64.5%), | 1.5% | [ | |
| Serbia | Carvacrol (64.5%), | NR | [ | |
| Serbia | Carvacrol (77.6%), | NR | [ | |
| Spain | Terpinen-4-ol (24.57%), carvacrol (16.09%), thymol (9.03%), γ-terpinene (6.20%). | 516 mg/plant | [ | |
| USA | Carvacrol (17.9–81.8%), | 0.114–2.312% | [ | |
| Algeria | Thymol (34.2%), carvacrol (30.5%), γ-terpinene (13.4%), | 2.0–2.2% | [ | |
| Algeria | Thymol (51.1%), γ-terpinene (14.5%), | 2.0–2.2% | [ | |
| Tunisia | 2.5–4.6% | [ | ||
| Tunisia | Thymol (31.8–46.1%), | 4.3–5.8% | [ | |
| Tunisia | Carvacrol (65.01%), | 1.87–3.42% | [ | |
| Iran | Carvacrol (46.86%), γ-terpinene (14.16%), | ≈2.0% | [ | |
| Turkey | Thymol (7.02–40.04%), carvacrol (8.21–33.21%), γ-terpinene (9.15–27.82%), | 0.25–0.50% | [ | |
| Argentina | NR | [ | ||
| Argentina | NR | [ | ||
| Argentina | γ-Terpinene (13.7%), terpinen-4-ol (11.2%), α-terpinene (9.9%), | NR | [ | |
| Colombia | Carvacrol (90.3%), thymol (3.5%), | NR | [ | |
| Greece | Carvacrol (70.38%), | NR | [ | |
| Greece | Carvacrol (90.29%), γ-terpinene (3.09%), | 7.77% | [ | |
| Greece | Carvacrol (81.28–91.21%), | 4.71–5.00% | [ | |
| Greece | Carvacrol (56.46–82.70%), | 0.63–4.25% | [ | |
| Hungary | Carvacrol (82.75%), | 4.46% | [ | |
| Italy | terpinen-4-ol (13.27–17.51%), γ-terpinene (14.58–14.95%), carvacrol (12.31–14.58%), | 0.063–0.165% | [ | |
| Italy | Thymol (37.9%), γ-terpinene (24.5%), | NR | [ | |
| Italy | γ-Terpinene (29.41%), thymol (26.86%), | 5.4% | [ | |
| Italy | Thymol (37.22%), γ-terpinene (26.37%), | 2.4% | [ | |
| Italy | Thymol (36.46%), γ-terpinene (20.77%), | 3.6% | [ | |
| Italy | Thymol (30.25%), γ-terpinene (25.89%), | 4.2% | [ | |
| Italy | Thymol y carvacrol (65.3–84.7%), linalool (0.1–2.6%), carvacrol methyl ether (0.4–1.9%). | 1.0–2.7% | [ | |
| Italy | Thymol (18.16–56.37%), γ-terpinene (12.70–32.70%), | 1.7–4.5% | [ | |
| Lithuania | Carvacrol (72.4–88.2%), γ-terpinene (4.1–8.7%), | 35.50–325.45 dm3/ha | [ | |
| Serbia | Carvacrol (74.65%), | 1.34% | [ | |
| Turkey | Linalool (96.31%), β-caryophyllene (1.27%). | 7.31% | [ | |
| Turkey | Carvacrol (80.09%), γ-terpinene (12.01%), | 5.9 ± 0.02% | [ | |
| Argentina | 2.17 ± 0.32 mg/g dw | [ | ||
| Iran | ( | ≈0.3% | [ | |
| Portugal | α-Terpineol (0.1–65.1%), γ-terpinene (0.3–34.25), linalool (2.0–27.4%), carvacrol (0–34.2%), | 0.8–1.2% | [ | |
| Argentina | NR | [ | ||
| Argentina | 1.97 ± 0.22 mg/g dw | [ | ||
| Iran | Thymol (37.13%), γ-terpinene (9.67%), carvacrol (9.57%), carvacrol methyl ether (6.88%). | 0.5% | [ | |
| Italy | Spathulenol (18.6%), carvacrol (11.7%), β-caryophyllene (8.8%), terpinen-4-ol (5.6%). | 0.13% | [ | |
| Italy | Carvacrol (14.3%), spathulenol (9.4%), β-caryophyllene (5.3%), terpinen-4-ol (5.0%). | 0.18% | [ | |
| Lithuania | Sabinene (6.6–28.2%), β-caryophyllene (7.3–15.5%), | 3.08–36.65 dm3/ha | [ | |
| Turkey | Thymol (58.31%), carvacrol (16.11%), | 5.09% | [ | |
| Poland | Sabinene (10.85–25.46%), | 0.66–0.86% | [ |
* dry weight (dw); NR: not reported.
Summarization of the biological activities of essential oils from oregano.
| Oregano Species | Biological Activity | Effect | Reference |
|---|---|---|---|
| Anti-inflammatory | Reduction on the levels of NO and ROS produced in murine macrophage cells. | [ | |
| Anti-inflammatory | Inhibition on the production of ROS and NO by LPS-stimulated RAW 264.7 macrophages | [ | |
| Antioxidant | Radical scavenging activity against DPPH | [ | |
| Anti-inflammatory | Reduction on the levels of NO and ROS produced in LPS-stimulated murine macrophage cells | [ | |
| Antioxidant | Showed scavenging activity against DPPH radical | [ | |
| Antioxidant | ABTS radical-scavenging activity | [ | |
| Cytotoxic | Nontoxic when used in MCF-7 cells | [ | |
| Antioxidant | Ferric reducing/antioxidant power | [ | |
| Antiproliferative | Inhibit colon carcinoma (LoVo) and hepatocarcinoma (HepG2) cell proliferation | [ | |
| Antioxidant | DPPH radical-scavenging activity | [ | |
| Antioxidant | Showed antiradical activity | [ | |
| Anti-inflammatory | Inhibition of NO production | [ | |
| Antioxidant | Ferric reducing/antioxidant power | [ | |
| Antiproliferative | Inhibit HepG2 cell proliferation | [ | |
| Anti-inflammatory | Reduction in the secretion of inflammatory cytokines (TNF-α, IL-1β and IL-6) in THP-1 cells | [ | |
| Anti-genotoxic | Reduces the chromosomal aberration in bone marrow cells of rats | [ | |
| Cytotoxic | Inhibit cell viability of human breast (MCF-7) and prostate (LNCaP) cancer cell lines. | [ | |
| Antioxidant | Showed ferric reducing power | [ | |
| Antioxidant | Retard lipidic oxidation | [ | |
| Antioxidant | Showed free radical scavenging against DPPH radical | [ | |
| Anti-angiogenic | Blocks in vitro tube formation | [ | |
| Anti-genotoxic | Reduces the effect of Aflatoxin B1 (AFB1) in human peripheral lymphocytes | [ | |
| Antioxidant | DPPH radical-scavenging activity | [ | |
| Antioxidant | Showed scavenging activity against DPPH radical | [ | |
| Antioxidant | Total reducing capacity (Folin-Ciocalteu method), radical-scavenging activity in the UV radiation-induced peroxidation in liposomal membranes | [ | |
| Antioxidant | Reduces 8-hydroxy-deoxyguanosine and thiobarbituric acid reactive substances. | [ | |
| Antioxidant | DPPH and ABTS radical-scavenging activity | [ | |
| Antiproliferative | Inhibit human lung adenocarcinoma epithelial (A549) cell proliferation | [ | |
| Cytotoxic | Decrease cell viability in a concentration-dependent manner on human keratinocyte (HaCaT) and lung cancer (A549) cell lines | [ | |
| Hypoglycemic | α-Amylase and α-glucosidase inhibitory activity | [ | |
| Antioxidant | Radical scavenging activity (DPPH, ABTS and FRAP assays). Total reducing capacity (Folin-Ciocalteu method) | [ | |
| Antioxidant | Prevent autoxidation of polyunsaturated fatty acid esters | [ | |
| Anti-inflammatory | Reduced synthesis of TNF-α, IL-1β, and IL-6 cytokines. Increased synthesis of cytokine IL-10 | [ | |
| Anti-inflammatory | Inhibition of the levels of inflammatory biomarkers (MCP-1, VCAM-1 and ICAM-1) on activated-primary human neonatal fibroblasts | [ | |
| Antiproliferative | Inhibit human breast adenocarcinoma (MCF-7) and human colon adenocarcinoma (HT-29) cell proliferation | [ | |
| Antitumor | Decrease the sizes of tumors in disease mice | [ | |
| Hypoglycemic | Inhibits α-amylase and α-glucosidase activity | [ |